The study also demonstrated that anti-CTLA-4 therapy could enhance the ability of cytotoxic T cells to eliminate neoplastic monocytes and granulocytes in coculture systems, suggesting that CTLA-4 blockade may augment immune responses against tumor cells. Here, CTLA4 is linked to neoplasm.